Akero Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Akero Therapeutics Inc
TickerAKRO
CIK #0001744659
CUSIP00973Y108
SectorLife Sciences - Pharmaceutical Preparations
Address170 Harbor Way, South San Francisco, CA 94080
Source [EDGAR]
CIK Filing 2011 - 2024
[0001744659] 10-K
[0001744659] 10-Q
[0001744659] 3
[0001744659] 4
[0001744659] 8-K
[0001744659] D
[0001744659] SC 13D
[0001744659] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Adage Capital Partners GP LLC Akero Therapeutics Inc [2023-04-10] 5.97
Redmile Group LLC Akero Therapeutics Inc [2023-02-14] 5.6
Price T Rowe Associates Inc /MD/ Akero Therapeutics Inc [2023-02-14] 5.1
Baker Bros Advisors LP Akero Therapeutics Inc [2023-02-14] 5.1
State Street Corp Akero Therapeutics Inc [2023-02-03] 5.35
BlackRock Inc Akero Therapeutics Inc [2023-02-03] 5.9
BlackRock Inc Akero Therapeutics Inc [2022-11-09] 4.9
Avidity Partners Management LP Akero Therapeutics Inc [2022-09-16] 6.9
Pfizer Inc Akero Therapeutics Inc [2022-06-28] 58.0
Goldman Sachs Group Inc Akero Therapeutics Inc [2022-02-08] 5.1
Wellington Management Group LLP Akero Therapeutics Inc [2022-02-04] 5.38
BlackRock Inc Akero Therapeutics Inc [2022-02-04] 5.6
Point72 Asset Management LP Akero Therapeutics Inc [2021-12-13] 5.0
Skorpios Trust Akero Therapeutics Inc [2021-06-30] 6.7
Redmile Group LLC Akero Therapeutics Inc [2021-02-16] 6.69
Alkeon Capital Management LLC Akero Therapeutics Inc [2021-02-11] 6.6
Janus Henderson Group PLC Akero Therapeutics Inc [2020-02-14] 8.4
Atlas Venture Fund Xi LP Akero Therapeutics Inc [2020-02-13] 0.5
Amgen Inc Akero Therapeutics Inc [2020-02-10] 9.0
Versant Venture Capital VI LP Akero Therapeutics Inc [2019-07-05] 14.7
Apple Tree Partners IV LP Akero Therapeutics Inc [2019-07-01] 19.4
venBio Global Strategic Fund II LP Akero Therapeutics Inc [2019-06-26] 14.17
Form 3/4/5 Filer 2011 - 2024
Cheng Andrew
Akero Therapeutics, Inc.
Graham G. Walmsley
Rolph Timothy
White William Richard
Yale Catriona
Young Jonathan
Lamy Patrick
Skorpios Trust
Blue Horizon Enterprise Ltd
Montrago Trustees Ltd
Ezbon International Ltd
Harrison Seth Loring
Heyman Tomas J.
Judy Chou
Xu Yuan
Henderson Jane
Iwicki Mark T
ATP Life Science Ventures, L.P.
ATP III GP, Ltd.
Bitterman Kevin
venBio Global Strategic GP II, L.P.
Adelman Robert J
venBio Global Strategic GP II, Ltd.
venBio Global Strategic Fund II L.P.
Goodman Corey S
Atlas Venture Opportunity Fund I, L.P.
Versant Ventures VI GP-GP, LLC
Versant Ventures VI GP, L.P.
Versant Venture Capital VI, L.P.
Atlas Venture Fund XI, L.P.
Atlas Venture Associates Opportunity I, L.P.
Atlas Venture Associates XI, LLC
Atlas Venture Associates Opportunity I, LLC
Atlas Venture Associates XI, L.P.
Royston Aaron
Green Jeremy
Redmile Group, LLC
Form 13F Holdings
Firm Period DFND Voting Shares
Janus Henderson Group PLC [2023-03-31] DFND 0.0 3,811,676.0
Skorpios Trust [2023-03-31] SOLE 3,271,829.0 3,271,829.0
BlackRock Inc. [2023-03-31] SOLE 2,706,722.0 2,783,377.0
Alkeon Capital Management LLC [2023-03-31] SOLE 2,722,242.0 2,722,242.0
Price T Rowe Associates Inc /MD/ [2023-03-31] SOLE 460,933.0 2,603,644.0
Avidity Partners Management LP [2023-03-31] SOLE 2,447,000.0 2,447,000.0
Adage Capital Partners GP LLC [2023-03-31] SOLE 2,389,891.0 2,389,891.0
Baker Bros Advisors LP [2023-03-31] SOLE 2,368,378.0 2,368,378.0
State Street Corp [2023-03-31] DFND 2,155,339.0 2,230,807.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 2,078,568.0
Redmile Group LLC [2023-03-31] SOLE 2,044,389.0 2,044,389.0
Rock Springs Capital Management LP [2023-03-31] SOLE 1,454,254.0 1,454,254.0
Yiheng Capital Management LP [2023-03-31] SOLE 1,125,791.0 1,289,591.0
Wellington Management Group LLP [2023-03-31] DFND 0.0 1,160,542.0
FMR LLC [2023-03-31] DFND 1,139,329.0 1,141,285.0
Marshall Wace LLP [2023-03-31] OTR 0.0 1,081,725.0
Citadel Advisors LLC [2023-03-31] DFND 933,108.0 933,108.0
Boxer Capital, LLC [2023-03-31] OTR 831,495.0 831,495.0
Commodore Capital LP [2023-03-31] SOLE 790,000.0 790,000.0
Geode Capital Management LLC [2023-03-31] DFND 665,927.0 665,927.0
Atlas Venture Life Science Advisors LLC [2023-03-31] SOLE 594,251.0 594,251.0
Perceptive Advisors LLC [2023-03-31] SOLE 523,525.0 523,525.0
Deutsche Bank AG [2023-03-31] DFND 89,449.0 519,575.0
Alkeon Capital Management LLC [2023-03-31] OTR 0.0 498,488.0
Logos Global Management LP [2023-03-31] SOLE 400,000.0 400,000.0
Eventide Asset Management LLC [2023-03-31] SOLE 379,120.0 379,120.0
D. E. Shaw & Co., Inc. [2023-03-31] DFND 368,011.0 368,011.0
Northern Trust Corp [2023-03-31] DFND 15,919.0 357,701.0
Morgan Stanley [2023-03-31] DFND 266,753.0 357,593.0
Susquehanna International Group LLP [2023-03-31] DFND 98,703.0 350,303.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com